Chrome Extension
WeChat Mini Program
Use on ChatGLM

Type I Interferon Signature in NOTCH1‐Related Leukoencephalopathy

Annals of Neurology(2023)

Cited 1|Views16
No score
Abstract
Annals of NeurologyVolume 93, Issue 5 p. 1041-1043 LETTERS/REPLIES Type I Interferon Signature in NOTCH1-Related Leukoencephalopathy Francesco Nicita MD, PhD, Corresponding Author Francesco Nicita MD, PhD [email protected] orcid.org/0000-0002-5612-821X Genetics and Rare Diseases Research Division, Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, Italy Address correspondence to Dr Nicita, Genetics and Rare Diseases Research Division, Unit of Neuromuscular and Neurodegenerative Diseases, Department of Neuroscience, IRCCS Bambino Gesù Children's Hospital, viale di San Paolo 15, 00146, Rome, Italy. E-mail: [email protected]Search for more papers by this authorLorena Travaglini PhD, Lorena Travaglini PhD Genetics and Rare Diseases Research Division, Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, ItalySearch for more papers by this authorValentina Matteo BSc, Valentina Matteo BSc Laboratory of Immuno-Rheumatology, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, ItalySearch for more papers by this authorChiara Aiello PhD, Chiara Aiello PhD Genetics and Rare Diseases Research Division, Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, ItalySearch for more papers by this authorDaniela Longo MD, Daniela Longo MD Neuroradiology Unit, Department of Imaging, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, ItalySearch for more papers by this authorAntonella Insalaco MD, Antonella Insalaco MD Division of Rheumatology, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, ItalySearch for more papers by this authorEnrico Bertini MD, Enrico Bertini MD Genetics and Rare Diseases Research Division, Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, ItalySearch for more papers by this authorGiusi Prencipe PhD, Giusi Prencipe PhD Laboratory of Immuno-Rheumatology, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, ItalySearch for more papers by this author Francesco Nicita MD, PhD, Corresponding Author Francesco Nicita MD, PhD [email protected] orcid.org/0000-0002-5612-821X Genetics and Rare Diseases Research Division, Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, Italy Address correspondence to Dr Nicita, Genetics and Rare Diseases Research Division, Unit of Neuromuscular and Neurodegenerative Diseases, Department of Neuroscience, IRCCS Bambino Gesù Children's Hospital, viale di San Paolo 15, 00146, Rome, Italy. E-mail: [email protected]Search for more papers by this authorLorena Travaglini PhD, Lorena Travaglini PhD Genetics and Rare Diseases Research Division, Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, ItalySearch for more papers by this authorValentina Matteo BSc, Valentina Matteo BSc Laboratory of Immuno-Rheumatology, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, ItalySearch for more papers by this authorChiara Aiello PhD, Chiara Aiello PhD Genetics and Rare Diseases Research Division, Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, ItalySearch for more papers by this authorDaniela Longo MD, Daniela Longo MD Neuroradiology Unit, Department of Imaging, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, ItalySearch for more papers by this authorAntonella Insalaco MD, Antonella Insalaco MD Division of Rheumatology, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, ItalySearch for more papers by this authorEnrico Bertini MD, Enrico Bertini MD Genetics and Rare Diseases Research Division, Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, ItalySearch for more papers by this authorGiusi Prencipe PhD, Giusi Prencipe PhD Laboratory of Immuno-Rheumatology, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, ItalySearch for more papers by this author First published: 09 March 2023 https://doi.org/10.1002/ana.26631Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article.Citing Literature Volume93, Issue5May 2023Pages 1041-1043 RelatedInformation
More
Translated text
Key words
leukoencephalopathy,<scp>interferon</scp>
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined